🇺🇸 FDA

Company profile · Sponsor

Changchun

Changchun GeneScience Pharmaceutical Co.,

C764413 · NMPA pharma CN
Pipeline
3
Drugs
0
Patents
0

Quick answer

Changchun (C764413) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker C764413
Exchange NMPA
Company type pharma
Headquarters CN

Pipeline (3)

Search pipeline →

  1. Gentuximab

    Changchun

    Advanced Gastric or Gastroesophageal Junction Cancer

    phase 2 small molecule completed

    1 trial

  2. PEG-somatropin

    Changchun

    Dwarfism

    phase 2 small molecule active

    1 trial

  3. PEG-somatropin

    Changchun

    Growth Hormone Deficiency

    approved mab active

    1 trial

Frequently asked questions

What is Changchun?

Changchun (C764413) is a pharma company. headquartered in CN. listed on NMPA. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Changchun sponsor?

We track 3 ClinicalTrials.gov-linked programs for Changchun, including Gentuximab and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Changchun company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.